These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 944131)

  • 1. Acute tolerance to barbiturate in the rat.
    Turnbull MJ; Watkins JW
    Eur J Pharmacol; 1976 Mar; 36(1):15-20. PubMed ID: 944131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of the factors affecting the sleeping time following intracerebroventricular administration of pentobarbitone sodium: effect of prior administration of centrally active drugs.
    Stevenson IH; Turnbull MJ
    Br J Pharmacol; 1974 Apr; 50(4):499-511. PubMed ID: 4155651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sensitivity of the brain to barbiturate during chronic administration and withdrawal of barbitone sodium in the rat.
    Stevenson IH; Turnbull MJ
    Br J Pharmacol; 1970 Jun; 39(2):325-33. PubMed ID: 5463901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional distribution of barbital in the brain of mice during the development of tolerance and physical dependence.
    Lin SC; Sutherland VC
    Res Commun Chem Pathol Pharmacol; 1977 Oct; 18(2):215-31. PubMed ID: 562525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms contributing to barbiturate intolerance in rats.
    Aston R
    Br J Pharmacol; 1973 Nov; 49(3):527-33. PubMed ID: 4777712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical dependence to barbital compared to pentobarbital. II. Tolerance characteristics.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):507-13. PubMed ID: 564951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased penetration of barbital through the bloodbrain barrier in the rat after pretreatment with probenecid.
    Wahlström G
    Acta Pharmacol Toxicol (Copenh); 1978 Oct; 43(4):260-5. PubMed ID: 716942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical dependence to barbital compared to pentobarbital. IV. Influence of elimination kinetics.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):526-40. PubMed ID: 564953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model for the rapid induction of barbiturate tolerance.
    Mann PA; Isom GE
    Proc West Pharmacol Soc; 1978; 21():387-90. PubMed ID: 693521
    [No Abstract]   [Full Text] [Related]  

  • 10. Some aspects of the changes induced by chronic barbital treatments in the male rat.
    Wahlström G
    Drug Alcohol Depend; 1979; 4(3-4):221-33. PubMed ID: 575087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barbital alteration of central nervous system sensitivity to hexobarbital in the rat.
    Schnell RC; Stoll RE; Prosser TD
    Psychopharmacology (Berl); 1976 May; 47(1):93-6. PubMed ID: 959468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar development of tolerance to barbital-induced inhibition of avoidance behavior and loss of righting reflex in rats.
    Richter JA; Harris PS; Hanford PV
    Pharmacol Biochem Behav; 1982 Mar; 16(3):467-71. PubMed ID: 7079283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of oestrogens and progestins on the response of mice to barbiturates.
    Blackham A; Spencer PS
    Br J Pharmacol; 1969 Sep; 37(1):129-39. PubMed ID: 5360338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of tricyclic antidepressants and barbiturates in barbiturate-tolerant and nontolerant rats.
    Liu SJ; Huang CL; Waters IW
    J Pharmacol Exp Ther; 1975 Aug; 194(2):285-95. PubMed ID: 1151759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of halothane-induced sleeping time in the rat: effect of prior administration of centrally active drugs.
    Turnbull MJ; Watkins JW
    Br J Pharmacol; 1976 Sep; 58(1):27-35. PubMed ID: 987820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of p-chlorophenylalanine on the acquisition of tolerance to the hypnotic effects of pentobarbital, barbital, and ethanol.
    Khanna JM; Kalant H; Lê AD; Mayer J; LeBlanc AE
    Can J Physiol Pharmacol; 1980 Sep; 58(9):1031-41. PubMed ID: 6450628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disulfiram enhances pharmacological activity of barbital and impairs its urinary elimination.
    Sharkawi M; Cianflone D
    Science; 1978 Aug; 201(4355):543-4. PubMed ID: 663674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous administration of barbital by pellet implantation.
    Flint BA; Ho IK
    J Pharmacol Methods; 1980 Sep; 4(2):127-39. PubMed ID: 7192783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CNS tolerance to the hypnotic effect of pentobarbital in rats by injections of pentobarbital suspension.
    Richter JA
    Neuropharmacology; 1979 Feb; 18(2):183-91. PubMed ID: 431785
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential sensitivity to ethanol, pentobarbital, and barbital in spontaneously hypertensive and normotensive Wistar-Kyoto rats.
    Khanna JM; Lê AD; Kalant H; Kim C
    Psychopharmacology (Berl); 1985; 86(3):296-301. PubMed ID: 3929299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.